![David M. Byers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
David M.
Byers is a scientific advisor and founder of DeNovaMed, Inc. which is founded in 2006.
He is currently a professor at Dalhousie University.
Postes actifs de David M. Byers
| Sociétés | Poste | Début |
|---|---|---|
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Fondateur | 01/01/2006 |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Dalhousie University
Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Health Technology |
